17-44075780-G-C
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_138387.4(G6PC3):c.778G>C(p.Gly260Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000114 in 1,612,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G260D) has been classified as Likely pathogenic.
Frequency
Consequence
NM_138387.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000560 AC: 14AN: 249872Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135272
GnomAD4 exome AF: 0.000120 AC: 175AN: 1459920Hom.: 0 Cov.: 33 AF XY: 0.000128 AC XY: 93AN XY: 726390
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74318
ClinVar
Submissions by phenotype
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency Pathogenic:4Other:1
- -
- -
- -
The p.Gly260Arg variant substitutes the glycine at amino acid position 260 with an arginine. This variant has been observed in the homozygous state or in trans with a second pathogenic variant in multiple unrelated individuals with G6PC3 (MIM: 612541; PMID: 23758768, PMID: 23180359, PMID: 19118303, PMID: 22050868). The p.Gly260Arg variant is an ancient founder variant found primarily in individuals of European ancestry (14 of 129,040 alleles, gnomAD v2.1.1; PMID: 23758768). Functional studies have shown that the p.Gly260Arg variant lacks hydrolytic activity (PMID: 25492228, McDermott et al., PMID: 20616219). -
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 260 of the G6PC3 protein (p.Gly260Arg). This variant is present in population databases (rs200478425, gnomAD 0.01%). This missense change has been observed in individuals with syndromic severe congenital neutropenia (PMID: 19118303, 20616219, 23180359, 23441086). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 30874). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt G6PC3 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects G6PC3 function (PMID: 25492228). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:3
- -
Published functional studies demonstrate a damaging effect with no detectable enzyme activity (PMID: 25492228); Reported as a common pathogenic variant among individuals of European background (PMID: 23758768); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23441086, 19118303, 19775295, 20220065, 20616219, 23180359, 25491320, 23758768, 25492228) -
PP1, PP3, PM3_very_strong, PS3_moderate, PS4 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at